Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-nodal gentamicin injection plus oral azithromycin for suppurated cat scratch disease lymphadenitis in adults
2016-001576-30Phase 2Active
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Nov 2016
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of gentamicin in cat scratch disease (CSD) and bartonellosis (2 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Unfavorable outcome of cat scratch disease lymphadenitis at day 28. Started Nov 2016; status: active.
02
Drugs
gentamicin
03
Conditions
cat scratch disease (CSD)bartonellosis
Beyond the preview
Go deeper on 2016-001576-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001576-30.